018202301

PRÉNUMBRA

---

February 26, 2020

Trademark Summary

The trademark application PRÉNUMBRA was filed by Clinuvel (UK) Ltd, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on March 19, 2020, and it was registered by office on June 26, 2020 without any oppositions.

It was designated 'Basic Application' for International Application 1555226 at the World Intellectual Property Organization (WIPO).

The application was filed in English (German was selected as the second language).

Change of name and professional address of the trademark registration was recorded on January 11, 2023. Change of name and professional address of the trademark registration was recorded on October 2, 2024.

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Pharmaceuticals
  2. Pharmaceutical drugs
  3. Pharmaceutical preparations
  4. Pharmaceuticals used for cerebrovascular accidents (strokes)
  5. Cardiovascular preparations
  6. Cardiovascular pharmaceuticals
  7. Cardiovascular pharmaceutical preparations
  8. Cardiovascular agents for medical purposes
  9. Cardiovascular drugs used in treating shocks
  10. Cardiovascular drugs used in myocardial infarctions
  11. Cardiovascular drugs used in treating arrhythmias
  12. Cardiovascular drugs used in angina pectoris
  13. Pharmaceutical preparations for the treatment of cardiovascular disease
  14. Cardiovascular drugs used in treating congestive heart failure (CHF)
  15. Pharmaceutical preparations, preferably based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide
  16. Sun tanning preparations for pharmaceutical purposes, preferably based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide
  17. Pharmaceutical preparations for skin care
  18. Pharmaceutical preparations for treating skin disorders
  19. Dermatological preparations
  20. Dermatological pharmaceutical substances
  21. Dermatological pharmaceutical products
  22. Medicinal creams for the protection of the skin
  23. Skin care creams for medical use
  24. Skin care preparations for medical use
  25. Medicated skin creams and lotions
  26. Medicated creams for application after exposure to the sun
  27. Pharmaceutical skin lotions
  28. Preparations for cleansing the skin for medical use
  29. Chemical and biological preparations, substances, reagents and compounds for the delivery and storage of pharmaceuticals which are preferably based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide
  30. Afamelanotide aqueous and gel formulations.